KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Tax Rate (2016 - 2025)

CRISPR Therapeutics AG's Tax Rate history spans 11 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Tax Rate fell 9.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.47%, down 1037.0%, while the annual FY2025 figure was 0.47%, 1034.0% down from the prior year.
  • Tax Rate for Q4 2025 was 0.23% at CRISPR Therapeutics AG, up from 0.58% in the prior quarter.
  • Across five years, Tax Rate topped out at 7.02% in Q4 2022 and bottomed at 3.4% in Q2 2022.
  • The 5-year median for Tax Rate is 0.55% (2021), against an average of 0.14%.
  • The largest annual shift saw Tax Rate skyrocketed 424bps in 2022 before it plummeted -677bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 2.77% in 2021, then surged by 153bps to 7.02% in 2022, then crashed by -97bps to 0.24% in 2023, then skyrocketed by 31bps to 0.32% in 2024, then dropped by -28bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for CRSP's Tax Rate are 0.23% (Q4 2025), 0.58% (Q3 2025), and 0.63% (Q2 2025).